Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04054050 · ClinicalTrials.gov registry record · NA
Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT04054050: Completed NA study, sponsored by Johns Hopkins University.
NCT04054050 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04054050, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
Sleep disturbance is common in people with multiple sclerosis (MS) and contributes to diminished quality of life. Bright light therapy may be an innovative strategy to reduce sleep disturbance in MS, possibly through its effects on a subtype of retinal ganglion cells that help regulate circadian rhythms and sleep. This pilot study will evaluate whether, in people with MS, bright light therapy reduces sleep disturbance and explore whether light therapy improves function of these cells.
Interventions
- OTHER Light therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2026-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04054050
The ClinicalTrials.gov registry entry for NCT04054050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Light therapy is the first listed.
NCT04054050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04054050 about?
NCT04054050 is a clinical study titled "Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis". Sleep disturbance is common in people with multiple sclerosis (MS) and contributes to diminished quality of life. Bright light therapy may be an innovative strategy to reduce sleep disturbance in MS, possibly through its effects on a subtype of retinal ganglion cells that help regulate circadian rhy...
What is the current status of trial NCT04054050?
This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2021-02-22. Estimated completion is 2026-01-30.
What interventions are being tested in trial NCT04054050?
The interventions under investigation include: Light therapy (OTHER).
Who is sponsoring clinical trial NCT04054050?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.